KESTER KING PAYUMO: Open Payments
NPI 1790457208 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 10 payments from 4 companies in 2025. Trend: 2023 $363 · 2024 $831 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $250 |
| Novartis Pharmaceuticals Corporation | 5 | $140 |
| Amgen Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: LEQVIO, Ozempic, Wegovy, REPATHA, VERQUVO.
Industry payments across NY — which companies pay providers there.
